By Carley Petesch, Associated Press Senegal and Rwanda have signed an agreement with German company BioNTech for the construction of its first start-to-finish factories to make messenger RNA vaccines in Africa. BioNTech, which developed the Pfizer-BioNTech COVID-19 vaccine, said Tuesday that construction will start in mid-2022. It is working with the Institut Pasteur in Dakar, […]
The post BioNTech to work with Senegal, Rwanda to make mRNA vaccines appeared first on Voice and Viewpoint.
